Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2026
Thymus engraftment and developmental progression of adoptively transferred progenitor T cells are affected by host conditioningYue Ru Li, Christina R Lee, Mahmood Mohtashami, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatisRobert S Kerbel, Eric Guerin, Giulio Francia, et al.
Molecular Cancer Therapeutics|April 27, 2018
Tumor-Independent Host Secretomes Induced By Angiogenesis and Immune-Checkpoint InhibitorsMichalis Mastri, Christina R Lee, Amanda Tracz, et al.
Cancer Cell|March 3, 2009
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesisJohn M L Ebos, Christina R Lee, William Cruz-Munoz, et al.
Cancer Research|September 10, 2009
Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1Chris Folkins, Yuval Shaked, Shan Man, et al.
Cell Reports|December 28, 2018
A Transient Pseudosenescent Secretome Promotes Tumor Growth after Antiangiogenic Therapy WithdrawalMichalis Mastri, Amanda Tracz, Christina R Lee, et al.
Cell Reports|June 9, 2021
Ontogenic timing, T cell receptor signal strength, and Notch signaling direct γδ T cell functional differentiation in vivoEdward L Y Chen, Christina R Lee, Patrycja K Thompson, et al.
Cancer Research|August 17, 2005
Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategyYuval Shaked, Urban Emmenegger, Giulio Francia, et al.
Science Translational Medicine|April 10, 2015
Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanibChristopher Jedeszko, Marta Paez-Ribes, Teresa Di Desidero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenograftsGiulio Francia, Shan Man, Chyan-Jang Lee, et al.
Pageof 4